leflunomide has been researched along with Glomerulonephritis, Minimal Change in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Excerpt | Relevance | Reference |
---|---|---|
" During the treatment, 8 patients had adverse effects which could be well tolerated." | 1.39 | Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease. ( Huang, J; Li, J; Liu, G; Xu, R; Zhang, Y; Zhou, J, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Zhao, C | 1 |
Cui, Z | 1 |
Zhang, Y | 2 |
Wang, F | 1 |
Wang, X | 1 |
Cheng, X | 1 |
Meng, L | 1 |
Liu, G | 2 |
Zhao, M | 1 |
Zhou, J | 1 |
Li, J | 1 |
Xu, R | 1 |
Huang, J | 1 |
2 other studies available for leflunomide and Glomerulonephritis, Minimal Change
Article | Year |
---|---|
Leflunomide therapy for adult patients with steroid-dependent minimal change disease or primary focal segmental glomerulosclerosis.
Topics: Adult; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Leflunomide; Nephrosis, Lipoid; Ne | 2022 |
Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
Topics: Adolescent; Adult; Drug Resistance; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomid | 2013 |